Abiopharma

🔍 DEL VALLE PEROCHENA ANTONIO (Executive)

Company: BYLINE BANCORP, INC. (BY)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Sold 300,000 shares of Common stock at $39.1 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,535,145.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common stock (Direct)
  Date: 2026-08-07 | Code: H | shares_owned_after: 40,808.00

Footnotes:

• F1: Sale to and repurchase by Byline Bancorp, Inc. ("the Issuer") of 300,000 shares of Common Stock (the "Shares") pursuant to a Stock Repurchase Agreement (the "Stock Repurchase Agreement") dated as of August 7, 2026 between MBG Investors I, L.P. and the Issuer. Under the Stock Repurchase Agreement, the Issuer agreed to purchase the Shares at a price of $39.10 per Share, which price was determined based on the five (5) day average closing price for the Common Stock on the NYSE for the period from July 27, 2026 through July 31, 2026.